What Purgo Biologics does

Purgo Biologics is a South Korea-based dental biomaterials manufacturer founded in 1999, specializing in bone graft materials and collagen-based regenerative solutions for guided bone regeneration (GBR) procedures. The company develops and produces porcine-derived bone mineral matrices, collagenated bone graft blocks (THE Graft Collagen, 85% hydroxyapatite and 15% Type I collagen), resorbable collagen membranes (THE Cover), non-resorbable PTFE membranes (OpenTex, OpenTex-TR), and PTFE sutures (Biotex), with additional products including BCPGraft, LegoGraft, and THE Allo. Its proprietary Biomimetic Regeneration Technology platform underpins a portfolio that addresses socket preservation, ridge augmentation, sinus floor augmentation, and periodontal regeneration procedures for dental implant and periodontal surgery applications.

The company operates two KGMP-certified manufacturing facilities in Seongnam, South Korea, supported by an R&D center in Pangyo Innovation Valley. It distributes products in 42 countries with regulatory approvals in 56 jurisdictions (FDA, CE, ANVISA, Health Canada, CDSCO, MFDS, NMPA, TFDA, GOST), maintaining direct subsidiaries Purgo USA (New York) and Purgo Europe (Challans, France). Purgo generates revenue through hardware sales of medical device products to dental healthcare professionals, targeting periodontists, oral surgeons, implantologists, and dental universities and hospitals. Its go-to-market combines direct sales in Korea, regional subsidiary operations, and distributor networks internationally, supported by clinical evidence from 89 publications including 47 SCI-indexed papers and academic partnerships including a KAID MOU.

Name

Purgo Biologics

Legal name

(주)푸르고바이오로직스 (주식회사)

Website

https://purgobio.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Purgo Biologics is a South Korean dental biomaterials manufacturer producing porcine-derived bone grafts, collagen membranes, and PTFE membranes for guided bone regeneration. The company serves dental surgeons and periodontists across 42 countries through direct subsidiaries and distributors.

Ownership category

akta.pro rank

Product category

Dental Biomaterials

NAICS

Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Dental Equipment & Supplies (3843), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industry

Dental Implant Surgery & Bone Grafting (HLABAEAB)

Keywords

• Dental bone graft
• Dental biomaterials
• Guided bone regeneration
• Collagen membranes
• Xenograft bone substitute

Headquarters

HQ city

Seongnam

HQ country

South Korea

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Dental Biomaterial Products: Revenue generated from the sale of dental bone graft materials, collagen membranes, and surgical accessories to dental healthcare professionals. Products include THE Graft Collagen blocks/rings, THE Graft particulate, THE Cover collagen membranes, OpenTex PTFE membranes, and Biotex sutures. Sold through direct distribution in Korea and export channels to international markets.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Purgo Biologics develops, manufactures, and distributes dental biomaterials including particulate and block xenograft bone graft substitutes (THE Graft, THE Graft Collagen), resorbable collagen membranes (THE Cover), PTFE membranes (OpenTex, OpenTex-TR), PTFE sutures (Biotex), biphasic calcium phosphate bone grafts (BCPGraft), and allograft products (THE Allo). The company serves dental professionals worldwide with products approved in 56 countries.

Product overview

Purgo Biologics is a dental biomaterials company offering a comprehensive product portfolio focused on bone graft materials and collagen-based regenerative solutions. The product lineup centers on THE Graft (particulate xenograft), THE Graft Collagen (collagenated block bone graft), THE Cover (resorbable collagen membrane), OpenTex and OpenTex-TR (PTFE membranes), Biotex (PTFE suture), along with additional bone graft variants including LegoGraft, BCPGraft, THE BCP, and THE Allo. The portfolio is designed for guided bone regeneration (GBR) procedures including socket preservation, ridge augmentation, sinus floor augmentation, and periodontal regenerative treatments, serving dental healthcare professionals across global markets.

Differentiator

Problem solved

Functional benefit

Brands

• THE Graft: Porcine-derived particulate bone graft substitute (over 95% hydroxyapatite).
• THE Graft Collagen
• THE Cover
• OpenTex
• OpenTex-TR
• Biotex
• BCPGraft
• LegoGraft

Quantifiable outcome

• THE Graft Collagen showed horizontal width decrease of 1.66 ± 1.80 mm (20.82%) comparable to Bio-Oss Collagen 1.70 ± 2.26 mm (21.50%) in ridge preservation
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Biomatlante (France)minorChannel Partner/ Reseller/ Distributor · 1 January 2003Exclusive distributor contract in Asia signed in 2003 for Biomatlante products. Historical partnership for distribution of French dental biomaterials in Asian markets.
• Rocky Mountain Tissue Bank (USA)minorChannel Partner/ Reseller/ Distributor · 1 January 2002Distributor contract signed in 2002 for US tissue bank products. Historical partnership for distribution of American tissue bank products.
• KAID (Korean Association of Implantology and Dentistry)coreStrategic or Co-development PartnerMOU signing partnership for academic collaboration and professional development in dental implantology. Partnership announced through official news and YouTube video coverage.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• botiss biomaterials: Germany-based dental regenerative biomaterials specialist offering cerabone (bovine xenograft), Jason (collagen membrane), and mucoderm — directly overlapping with Purgo's THE Graft, THE Cover, and OpenTex portfolio across Europe and adjacent markets. Comparable in scale and product breadth as a focused dental biomaterials pure-play.
• RTI Surgical: US-based tissue processor offering allograft and xenograft bone graft substitutes for dental and orthopedic applications. Comparable in being a focused regenerative biomaterials manufacturer serving dental specialists, though with broader orthopedic exposure and a different sourcing model (human tissue vs. porcine like Purgo).
• LifeNet Health: Non-profit tissue bank offering allograft dental bone grafts (DermACELL, OraGraft) and other regenerative products. Comparable in supplying dental professionals with scientifically validated graft materials, but focused on allograft rather than Purgo's porcine xenograft pathway.
• Geistlich Pharma: Swiss-headquartered global leader in dental bone regeneration with Bio-Oss (bovine xenograft) and Bio-Gide (collagen membrane), the gold-standard products Purgo's THE Graft Collagen and THE Cover compete directly against in GBR procedures. Both serve periodontists, oral surgeons, and implantologists with comparable xenograft + membrane combinations.
• Osteogenics Biomedical: US dental regenerative products company specializing in PTFE membranes (Cytoplast), bone graft materials, and sutures — directly comparable product portfolio to Purgo's OpenTex, OpenTex-TR, and Biotex. Serves the same dental implant and periodontal specialists with focused, non-resorbable membrane expertise.

Broad incumbents

• Straumann Group: Swiss dental implant leader whose botiss acquisition (majority stake) and XenoFlex/XenoProt product lines make it a broad incumbent in dental regeneration. Competes with Purgo via botiss products and bundled implant + biomaterial solutions for the same periodontist and oral surgeon customer base.
• Dentsply Sirona: Global dental equipment and materials major offering regenerative solutions (Symbios, OSSIX membranes) within its broader implant and digital dentistry portfolio. Competes for the same dental specialist customers but typically as part of multi-product vendor relationships rather than as a focused biomaterials specialist like Purgo.
• Zimmer Biomet (Dental Division): Global medical device major whose dental division (now ZimVie) offers RegenerOss allograft and xenograft bone graft substitutes alongside membranes. A much larger competitor with broader portfolio including implants and surgical instruments, but directly overlaps in dental bone graft and membrane categories.

Emerging players

• Meccellis Biotech: France-based emerging developer of collagen-based dental membranes and bone graft substitutes. Comparable emerging specialist in dental regenerative biomaterials with similar clinical evidence strategy; Purgo's Purgo Europe subsidiary in Challans, France positions the two as direct regional competitors in the French market.
• NovaBone Products: US-based manufacturer specializing in synthetic calcium phosphate bone graft substitutes for dental and orthopedic applications. Represents an alternative material pathway to Purgo's porcine xenograft, addressing the religious/cultural restrictions that limit xenograft adoption and offering price competition in cost-sensitive markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights2 records

Customer concentration

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Purgo Biologics